Home Cart Sign in  
Chemical Structure| 1173699-31-4 Chemical Structure| 1173699-31-4

Structure of AMG-337
CAS No.: 1173699-31-4

Chemical Structure| 1173699-31-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AMG-337 is a potent, highly selective and ATP-competitive MET kinase inhibitor with an IC50 of < 5nM in enzymatic assays.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AMG-337

CAS No. :1173699-31-4
Formula : C23H22FN7O3
M.W : 463.46
SMILES Code : O=C1C2=C(N=CC(OCCOC)=C2)C=CN1[C@@H](C3=NN=C4C(F)=CC(C5=CN(C)N=C5)=CN43)C
MDL No. :MFCD29472283
InChI Key :DWHXUGDWKAIASB-CQSZACIVSA-N
Pubchem ID :44181686

Safety of AMG-337

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of AMG-337

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Madin-Darby Canine Kidney II (MDCK) cells 0.001, 0.01, 0.03, 0.1, 0.3, 1, 3, and 10 μM 2 hours To determine the inhibitory effect of AMG 337 on adenosine uptake in dog MDCK cells. Results showed an IC50 of 0.17 μM. PMC6657233

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Beagle dogs Conscious freely moving dogs Oral 30 mg/kg For 10 consecutive days To evaluate the effects of AMG 337 on hemodynamic function in dogs. Results showed AMG 337 caused decreases in blood pressure and increases in heart rate. PMC6657233

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.16mL

0.43mL

0.22mL

10.79mL

2.16mL

1.08mL

21.58mL

4.32mL

2.16mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories